You are here

  • Home
  • Archive
  • Volume 7, Issue 3
  • Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study

Article info

Article menu

Download PDFPDF

XML
Intensive care
Protocol
Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study

Authors

  • Lisa Burry Department of Pharmacy, Mount Sinai Hospital, and Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada PubMed articlesGoogle scholar articles
  • Damon Scales Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada PubMed articlesGoogle scholar articles
  • David Williamson Department of Pharmacy, Hôpital du Sacré-Coeur de Montréal, and Faculté de pharmacie, Université de Montréal, Montréal, Canada PubMed articlesGoogle scholar articles
  • Jennifer Foster Department of Critical Care, IWK Health Centre, and Dalhousie University, Halifax, Canada PubMed articlesGoogle scholar articles
  • Sangeeta Mehta Department of Medicine and Interdepartmental Division of Critical Care Medicine, Mount Sinai Hospital and University of Toronto, Toronto, Canada PubMed articlesGoogle scholar articles
  • Melanie Guenette Department of Pharmacy, Mount Sinai Hospital, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Eddy Fan Interdepartmental Division of Critical Care Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada PubMed articlesGoogle scholar articles
  • Michael Detsky Department of Medicine, University of Toronto, Toronto, Ontario, Canada Department of Medicine, University of Toronto and Department of Medicine, Mount Sinai Hospital, Toronto, Canada PubMed articlesGoogle scholar articles
  • Azar Azad Mount Sinai Services, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada PubMed articlesGoogle scholar articles
  • Francis Bernard Département de Médecine, Hôpital du Sacré-Cœur de Montréal, and Département de Médecine, Université de Montréal, Montreal, Canada Département de Médecine, Université de Montréal, Montreal, Quebec, Canada PubMed articlesGoogle scholar articles
  • Louise Rose Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, and Lawrence S. Bloomberg Faculty of Nursing and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Lisa Burry; lisa.burry{at}sinaihealthsystem.ca
View Full Text

Citation

Burry L, Scales D, Williamson D, et al
Feasibility of melatonin for prevention of delirium in critically ill patients: a protocol for a multicentre, randomised, placebo-controlled study
BMJ Open 2017;7:e015420. doi: 10.1136/bmjopen-2016-015420

Publication history

  • Received December 2, 2016
  • Revised January 31, 2017
  • Accepted February 24, 2017
  • First published March 30, 2017.
Online issue publication 
October 25, 2017
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/